Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keiko Mitamura

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Vaccine|January 24, 2018
Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016Norio Sugaya, Masayoshi Shinjoh, Yuji Nakata, et al.
Lancet (London, England)|September 1, 2004
Resistant influenza A viruses in children treated with oseltamivir: descriptive studyMaki Kiso, Keiko Mitamura, Yuko Sakai-Tagawa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in childrenNorio Sugaya, Keiko Mitamura, Masahiko Yamazaki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 14, 2004
[Evaluation of an immunochromatography test using enzyme immunoassay for rapid detection of influenza A and B viruses]Keiko Mitamura, Masahiko Yamazaki, Masataka Ichikawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|October 29, 2004
[Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses]Masahiko Yamazaki, Keiko Mitamura, Masataka Ichikawa, et al.
Antiviral Therapy|May 17, 2014
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitorNorio Sugaya, Yuko Sakai-Tagawa, Masahiro Bamba, et al.
JAMA|April 5, 2007
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsShuji Hatakeyama, Norio Sugaya, Mutsumi Ito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitorsDaisuke Tamura, Norio Sugaya, Makoto Ozawa, et al.
Internal Medicine (Tokyo, Japan)|March 28, 2022
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in JapanTakayuki Fujii, Masao Hagihara, Keiko Mitamura, et al.
Antiviral Research|June 24, 2020
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatmentEmi Takashita, Takashi Abe, Hiroko Morita, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Vaccine|January 24, 2018
Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013-2016Norio Sugaya, Masayoshi Shinjoh, Yuji Nakata, et al.
Lancet (London, England)|September 1, 2004
Resistant influenza A viruses in children treated with oseltamivir: descriptive studyMaki Kiso, Keiko Mitamura, Yuko Sakai-Tagawa, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 19, 2006
Lower clinical effectiveness of oseltamivir against influenza B contrasted with influenza A infection in childrenNorio Sugaya, Keiko Mitamura, Masahiko Yamazaki, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 14, 2004
[Evaluation of an immunochromatography test using enzyme immunoassay for rapid detection of influenza A and B viruses]Keiko Mitamura, Masahiko Yamazaki, Masataka Ichikawa, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|October 29, 2004
[Evaluation of flow-through immunoassay for rapid detection of influenza A and B viruses]Masahiko Yamazaki, Keiko Mitamura, Masataka Ichikawa, et al.
Antiviral Therapy|May 17, 2014
Comparison between virus shedding and fever duration after treating children with pandemic A H1N1/09 and children with A H3N2 with a neuraminidase inhibitorNorio Sugaya, Yuko Sakai-Tagawa, Masahiro Bamba, et al.
JAMA|April 5, 2007
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitorsShuji Hatakeyama, Norio Sugaya, Mutsumi Ito, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 21, 2011
Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitorsDaisuke Tamura, Norio Sugaya, Makoto Ozawa, et al.
Internal Medicine (Tokyo, Japan)|March 28, 2022
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in JapanTakayuki Fujii, Masao Hagihara, Keiko Mitamura, et al.
Antiviral Research|June 24, 2020
Influenza A(H1N1)pdm09 virus exhibiting reduced susceptibility to baloxavir due to a PA E23K substitution detected from a child without baloxavir treatmentEmi Takashita, Takashi Abe, Hiroko Morita, et al.
Pageof 6